Aytu BioPharma, Inc (AYTU) stock
AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3070% below fair value
$2.66+0.84 (+46.15%)
Close on Nov 17, 2026Market cap $28.91MP/E –Yield –
Aytu BioPharma EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Aytu BioPharma's EV/EBITDA was 2.8× on Jul 31, 2025, against 6.1× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 2.8× | +1.4 |
| 2024 | Dec 31, 2024 | 1.4× | – |
See a number that looks wrong?